187 related articles for article (PubMed ID: 31925917)
1. Randomized controlled trial comparing long-pulsed 1064-Nm neodymium: Yttrium-aluminum-garnet laser alone, topical amorolfine nail lacquer alone, and a combination for nondermatophyte onychomycosis treatment.
Bunyaratavej S; Wanitphakdeedecha R; Ungaksornpairote C; Kobwanthanakun W; Chanyachailert P; Nokdhes YN; Patthamalai P; Tantrapornpong P; Suphatsathienkul P; Kiratiwongwan R; Limphoka P; Leeyaphan C
J Cosmet Dermatol; 2020 Sep; 19(9):2333-2338. PubMed ID: 31925917
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy for onychomycosis using a fractional 2940-nm Er:YAG laser and 5 % amorolfine lacquer.
Zhang J; Lu S; Huang H; Li X; Cai W; Ma J; Xi L
Lasers Med Sci; 2016 Sep; 31(7):1391-6. PubMed ID: 27339057
[TBL] [Abstract][Full Text] [Related]
3. Randomized Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy with Short-Pulsed 1,064-nm Neodymium-Doped Yttrium Aluminium Garnet Laser and Amorolfine Nail Lacquer for Onychomycosis.
Park KY; Suh JH; Kim BJ; Kim MN; Hong CK
Ann Dermatol; 2017 Dec; 29(6):699-705. PubMed ID: 29200757
[TBL] [Abstract][Full Text] [Related]
4. Comparison of a fractional 2940-nm Er:YAG laser and 5% amorolfine lacquer combination therapy versus a 5% amorolfine lacquer monotherapy for the treatment of onychomycosis: a randomized controlled trial.
Zhang J; Zhang Y; Qin J; Lu S; Cai W; Li J; Huang H; Yang S; Xi L
Lasers Med Sci; 2021 Feb; 36(1):147-152. PubMed ID: 32557000
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of 5% amorolfine nail lacquer in Neoscytalidium dimidiatum onychomycosis.
Bunyaratavej S; Leeyaphan C; Rujitharanawong C; Surawan TM; Muanprasat C; Matthapan L
J Dermatolog Treat; 2016 Aug; 27(4):359-63. PubMed ID: 26471716
[TBL] [Abstract][Full Text] [Related]
6. Predisposing factors, clinical features and treatment outcomes of Fusarium onychomycosis and comparison of its characteristics with Neoscytalidium onychomycosis.
Phaitoonwattanakij S; Leeyaphan C; Lertrujiwanit K; Bunyaratavej S
J Mycol Med; 2021 Sep; 31(3):101165. PubMed ID: 34171603
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ
Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
[TBL] [Abstract][Full Text] [Related]
8. Lack of efficacy with 1064-nm neodymium:yttrium-aluminum-garnet laser for the treatment of onychomycosis: a randomized, controlled trial.
Hollmig ST; Rahman Z; Henderson MT; Rotatori RM; Gladstone H; Tang JY
J Am Acad Dermatol; 2014 May; 70(5):911-7. PubMed ID: 24641985
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis.
Rigopoulos D; Katoulis AC; Ioannides D; Georgala S; Kalogeromitros D; Bolbasis I; Karistinou A; Christofidou E; Polydorou D; Balkou P; Fragouli E; Katsambas AD
Br J Dermatol; 2003 Jul; 149(1):151-6. PubMed ID: 12890209
[TBL] [Abstract][Full Text] [Related]
10. A randomised comparative study of 1064 nm Neodymium-doped yttrium aluminium garnet (Nd:YAG) laser and topical antifungal treatment of onychomycosis.
Kim TI; Shin MK; Jeong KH; Suh DH; Lee SJ; Oh IH; Lee MH
Mycoses; 2016 Dec; 59(12):803-810. PubMed ID: 27402466
[TBL] [Abstract][Full Text] [Related]
11. Treatment of onychomycosis using a submillisecond 1064-nm neodymium:yttrium-aluminum-garnet laser.
Carney C; Cantrell W; Warner J; Elewski B
J Am Acad Dermatol; 2013 Oct; 69(4):578-82. PubMed ID: 23856649
[TBL] [Abstract][Full Text] [Related]
12. The use of the Er:YAG 2940nm laser associated with amorolfine lacquer in the treatment of onychomycosis.
Morais OO; Costa IM; Gomes CM; Shinzato DH; Ayres GM; Cardoso RM
An Bras Dermatol; 2013; 88(5):847-9. PubMed ID: 24173203
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of amorolfine 5% nail lacquer in combination with systemic antifungal agents for onychomycosis: A meta-analysis and systematic review.
Feng X; Xiong X; Ran Y
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28097731
[TBL] [Abstract][Full Text] [Related]
14. A multicenter, randomized, open-label, controlled study comparing the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution with amorolfine nail lacquer alone in dermatophytic onychomycosis.
Paul C; Coustou D; Lahfa M; Bulai-Livideanu C; Doss N; Mokthar I; Turki H; Nouira R; Fazaa B; Ben Osman A; Zourabichvili O; Cazeau C; Coubetergues H; Picot S; Bienvenu AL; Voisard JJ
Dermatology; 2013; 227(2):157-64. PubMed ID: 24051622
[TBL] [Abstract][Full Text] [Related]
15. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
[TBL] [Abstract][Full Text] [Related]
16. A multicentre, randomised, parallel-group, double-blind, vehicle-controlled and open-label, active-controlled study (versus amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis.
Blume-Peytavi U; Tosti A; Falqués M; Tamarit ML; Carreño C; Galván J; Tebbs V
Mycoses; 2022 Apr; 65(4):392-401. PubMed ID: 34752667
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region.
Baran R; Feuilhade M; Combernale P; Datry A; Goettmann S; Pietrini P; Viguie C; Badillet G; Larnier C; Czernielewski J
Br J Dermatol; 2000 Jun; 142(6):1177-83. PubMed ID: 10848743
[TBL] [Abstract][Full Text] [Related]
18. Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis.
Schaller M; Sigurgeirsson B; Sarkany M
Mycoses; 2017 Dec; 60(12):800-807. PubMed ID: 28925059
[TBL] [Abstract][Full Text] [Related]
19. The Energy Density and Treatment Times Are the Main Factors That Affect the Efficacy of Long-Pulsed 1,064-nm Nd:YAG Laser Treatment for Onychomycosis Caused by Trichophyton rubrum.
Liu C; Zhang L; Zeng HY; Bei H; Chen SP; Wu YX; Luo WX; Fang Q; Liu PM
Dermatology; 2018; 234(3-4):105-111. PubMed ID: 30041183
[TBL] [Abstract][Full Text] [Related]
20. Topical treatment of onychomycosis with amorolfine 5% nail lacquer: comparative efficacy and tolerability of once and twice weekly use.
Reinel D
Dermatology; 1992; 184 Suppl 1():21-4. PubMed ID: 1532336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
